- Home
- Publications
- Publication Search
- Publication Details
Title
Richter Syndrome
Authors
Keywords
-
Journal
Current Oncology Reports
Volume 23, Issue 3, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-14
DOI
10.1007/s11912-020-01001-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Feasibility and efficacy of CD19-targeted CAR-T cells with concurrent ibrutinib for CLL after ibrutinib failure
- (2020) Jordan Gauthier et al. BLOOD
- A multicenter phase II study of venetoclax plus dose-adjusted R-EPOCH (VR-EPOCH) for Richter’s syndrome.
- (2020) Matthew Steven Davids et al. JOURNAL OF CLINICAL ONCOLOGY
- Richter transformation in chronic lymphocytic leukemia (CLL)—a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials
- (2020) O. Al-Sawaf et al. LEUKEMIA
- Clinical outcome and prognostic factors of patients with Richter syndrome: real‐world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC)
- (2020) Pau Abrisqueta et al. BRITISH JOURNAL OF HAEMATOLOGY
- Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study
- (2019) Anas Younes et al. Lancet Haematology
- Clinical characteristics and outcomes of Richter transformation: Experience of 204 patients from a single center
- (2019) Yucai Wang et al. HAEMATOLOGICA
- BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome
- (2018) Andrea Visentin et al. BRITISH JOURNAL OF HAEMATOLOGY
- BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia
- (2017) Jennifer A. Woyach et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity and tolerability of the Bruton's tyrosine kinase (Btk) inhibitor PCI-32765 in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): Interim results of a phase Ib/II study.
- (2017) J. C. Byrd et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience
- (2016) A. R. Mato et al. BLOOD
- NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome
- (2016) Toby A. Eyre et al. BRITISH JOURNAL OF HAEMATOLOGY
- Diagnostic dilemmas of high-grade transformation (Richter's syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP-OR clinical trial specialist haemato-pathology central review
- (2016) Elizabeth J Soilleux et al. HISTOPATHOLOGY
- An 18F-FDG-PET maximum standardized uptake value > 10 represents a novel valid marker for discerning Richter’s Syndrome
- (2016) Anne-Sophie Michallet et al. LEUKEMIA & LYMPHOMA
- Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma
- (2016) Peter Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison tode novoHodgkin lymphoma
- (2015) Sameer A. Parikh et al. AMERICAN JOURNAL OF HEMATOLOGY
- Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8
- (2015) M. Gounari et al. BLOOD
- Perturbation of the normal immune system in patients with CLL
- (2015) F. Forconi et al. BLOOD
- The efficacy of ibrutinib in the treatment of Richter syndrome
- (2015) M. Tsang et al. BLOOD
- XIV. The pathology of transformation of indolent B cell lymphomas
- (2015) Randy D. Gascoyne HEMATOLOGICAL ONCOLOGY
- Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease
- (2015) F R Mauro et al. LEUKEMIA
- Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK
- (2015) Idit Sagiv-Barfi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ibrutinib has some activity in Richter’s syndrome
- (2015) S Giri et al. Blood Cancer Journal
- Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation
- (2014) Petra Langerbeins et al. AMERICAN JOURNAL OF HEMATOLOGY
- Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia
- (2014) L. Falchi et al. BLOOD
- Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
- (2014) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome
- (2013) E. Chigrinova et al. BLOOD
- Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients
- (2013) Sameer A. Parikh et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phase I-II Clinical Trial of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Therapy in Aggressive Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome
- (2013) Apostolia M. Tsimberidou et al. Clinical Lymphoma Myeloma & Leukemia
- Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome
- (2013) Giulia Fabbri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
- (2013) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome
- (2012) Davide Rossi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Autologous and Allogeneic Stem-Cell Transplantation for Transformed Chronic Lymphocytic Leukemia (Richter's Syndrome): A Retrospective Analysis From the Chronic Lymphocytic Leukemia Subcommittee of the Chronic Leukemia Working Party and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
- (2012) Kate Cwynarski et al. JOURNAL OF CLINICAL ONCOLOGY
- NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome
- (2012) N Villamor et al. LEUKEMIA
- MGA, a suppressor ofMYC, is recurrently inactivated in high risk chronic lymphocytic leukemia
- (2012) Lorenzo De Paoli et al. LEUKEMIA & LYMPHOMA
- Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
- (2011) D. Rossi et al. BLOOD
- The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation
- (2011) D. Rossi et al. BLOOD
- Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature
- (2011) Bruno Bockorny et al. BRITISH JOURNAL OF HAEMATOLOGY
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- (2011) Xose S. Puente et al. NATURE
- Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior
- (2010) E. Gine et al. HAEMATOLOGICA
- Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
- (2010) William G. Wierda et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome
- (2009) D. Rossi et al. CLINICAL CANCER RESEARCH
- Phase I-II Study of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Combination Therapy in Patients With Richter's Syndrome or Fludarabine-Refractory Chronic Lymphocytic Leukemia
- (2008) Apostolia M. Tsimberidou et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started